Journal Club 2015.09.18.

Histamine Released from Epidermal Keratinocytes Plays a Role in a-MelanocyteeStimulating Hormone-Induced Itching in Mice

Histamine Released from Epidermal Keratinocytes Plays a Role in α-Melanocyte–Stimulating Hormone-Induced Itching in Mice

Kyoko Shimizu,* Tsugunobu Andoh,y Yoko Yoshihisa,* and Tadamichi Shimizu*
From the Departments of Dermatology* and Applied Pharmacology,y Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
Accepted for publication July 14, 2015.
Address correspondence to Tadamichi Shimizu, Depart- ment of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, Japan. E-mail: shimizut@med.u- toyama.ac.jp.

Sunburn, wound repair, and chronic renal failure with hemodialysis are usually accompanied by both pigmentation and itching. Proopiomelanocortin-derived a-melanocyteestimulating hormone (a-MSH) is produced in response to external stimuli, such as UV irradiation, and is involved in cutaneous pigmen- tation. However, it is unclear whether a-MSH is also involved in the itching. We therefore investigated whether a-MSH elicited itch-related responses in mice. We found that an intradermal injection of a-MSH induced hind-paw scratching, an itch-related response, in mice. The a-MSHeinduced scratching was inhibited by the m-opioid receptor antagonist naltrexone and the H1 histamine receptor antagonist terfenadine. In mast cell-deficient mice, a-MSH also elicited scratching, which was inhibited by terfe- nadine. The immunoreactivity for L-histidine decarboxylase, a key enzyme required for the production of histamine, histamine, and the melanocortin 1 and 5 receptors were shown in not only mast cells but also keratinocytes in murine skin. In addition to the expression of L-histidine decarboxylase and melanocortin 1 and 5 receptors, the mouse keratinocyte cell lines (Pam212) also showed immunoreactivity for L-his- tidine decarboxylase, histamine, and melanocortin 1 and 5 receptors. The application of a-MSH induced the release of histamine from Pam212 cells. These findings indicate that a-MSH may play an important role in the itching associated with pigmented cutaneous lesions and that the histamine released from keratinocytes is involved in this a-MSHeinduced itching. (Am J Pathol 2015, -: 1e8; http://dx.doi.org/ 10.1016/j.ajpath.2015.07.015)

Journal Club 2015.09.11.

Antipruritic mechanisms of topical E6005, a phosphodiesterase
4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP
Tsugunobu Andoh, Yasushi Kuraishi *
Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan

1-s2.0-S0923181114002497-main

ABSTRACT
Background: Phosphodiesterase 4 (PDE4), which catalyses the conversion of cyclic adenosine 30,50- monophosphate (cAMP) to 50-AMP, plays a critical role in the pathogenesis of inflammatory disorders. Pruritus is the main symptom of dermatitides, such as atopic dermatitis, and is very difficult to control. Recent studies have shown that the activation of proteinase-activated receptor 2 (PAR2) is involved in pruritus in dermatoses in humans and rodents.
Objective: To investigate the inhibitory effect of E6005, a topically effective PDE4 inhibitor, on PAR2-associated itching in mice.
Methods: Mice were given an intradermal injection of SLIGRL-NH2 (100 nmol/site), a PAR2 agonist peptide, into the rostral part of the back. E6005 and 8-bromo-cAMP were applied topically and injected intradermally, respectively, to the same site. Scratching bouts were observed as an itch-related behavior, and firing activity of the cutaneous nerve was electrophysiologically recorded. Keratinocytes were isolated from the skin of neonatal mice and cultured for in vitro experiments. The concentrations of cAMP and leukotriene B4 (LTB4) were measured by enzyme immunoassay. The distribution of PDE4 subtypes in the skin was investigated by immunostaining.
Results: Topical E6005 and intradermal 8-bromo-cAMP significantly inhibited SLIGRL-NH2-induced scratching and cutaneous nerve firing. Topical E6005 increased cutaneous cAMP content. Topical E6005 and intradermal 8-bromo-cAMP inhibited cutaneous LTB4 production induced by SLIGRL-NH2, which has been shown to elicit LTB4-mediated scratching. E6005 and 8-bromo-cAMP inhibited SLIGRL-NH2- induced LTB4 production in the cultured murine keratinocytes also. PDE4 subtypes were mainly expressed in keratinocytes and mast cells in the skin.
Conclusions: The results suggest that topical E6005 treatment inhibits PAR2-associated itching. Inhibition of LTB4 production mediated by an increase in cAMP may be partly involved in the antipruritic action of E6005.
ß 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Journal Club 2015.08.28.

Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs

ncomms8864

Vemuri B. Reddy1,*, Shuohao Sun2,*, Ehsan Azimi1, Sarina B. Elmariah1, Xinzhong Dong2 & Ethan A. Lerner1
Sensory neurons expressing Mas-related G-protein-coupled receptors (Mrgprs) mediate histamine-independent itch. We show that the cysteine protease cathepsin S activates MrgprC11 and evokes receptor-dependent scratching in mice. In contrast to its activation of conventional protease-activated receptors, cathepsin S-mediated activation of MrgprC11 did not involve the generation of a tethered ligand. We demonstrate further that different cysteine proteases selectively activate specific mouse and human Mrgpr family members. This expansion of our understanding by which proteases interact with G-protein-coupled receptors (GPCRs) redefines the concept of what constitutes a protease-activated receptor. The findings also implicate proteases as ligands to members of this orphan receptor family while providing new insights into how cysteine proteases contribute to itch.

Journal club 2015.07.24.

Polysulfide evokes acute pain through the activation of nociceptive TRPA1 in mouse sensory neurons
Yukari Hatakeyama1, Kenji Takahashi1, Makoto Tominaga2, Hideo Kimura3 and Toshio Ohta1*

s12990-015-0023-4

Abstract
Background: Hydrogen sulfide (H2S) is oxidized to polysulfide. Recent reports show that this sulfur compound modulates various biological functions. We have reported that H2S is involved in inflammatory pain in mice. On the other hand, little is known about the functional role of polysulfide in sensory neurons. Here we show that polysulfide selectively stimulates nociceptive TRPA1 and evokes acute pain, using TRPA1-gene deficient mice (TRPA1(−/−)), a heterologous expression system and a TRPA1-expressing cell line.
Results: In wild-type mouse sensory neurons, polysulfide elevated the intracellular Ca concentration ([Ca2+]i) in a dose-dependent manner. The half maximal effective concentration (EC50) of polysulfide was less than one-tenth that of H2S. The [Ca2+]i responses to polysulfide were observed in neurons responsive to TRPA1 agonist and were inhibited by blockers of TRPA1 but not of TRPV1. Polysulfide failed to evoke [Ca2+]i increases in neurons from TRPA1(−/−) mice. In RIN-14B cells, constitutively expressing rat TRPA1, polysulfide evoked [Ca2+]i increases with the same EC50 value as in sensory neurons. Heterologously expressed mouse TRPA1 was activated by polysulfide and that was suppressed by dithiothreitol. Analyses of the TRPA1 mutant channel revealed that cysteine residues located in the internal domain were related to the sensitivity to polysulfide. Intraplantar injection of polysulfide into the mouse hind paw induced acute pain and edema which were significantly less than in TRPA1(−/−) mice.
Conclusions: The present data suggest that polysulfide functions as pronociceptive substance through the activation of TRPA1 in sensory neurons. Since the potency of polysulfide is higher than parental H2S and this sulfur compound is generated under pathophysiological conditions, it is suggested that polysulfide acts as endogenous ligand for TRPA1. Therefore, TRPA1 may be a promising therapeutic target for endogenous sulfur compound-related algesic action.
Keywords: Transient Receptor Potential Channels (TRP Channels), Calcium imaging, Dorsal root ganglia, Heterologous expression

Journal club 2015.07.17.

A Sensory Neuron-expressed Interleukin-31 Receptor Mediates T helper Cell-dependent Itch: Involvement of TRPV1 and TRPA1

nihms540721

Ferda Cevikbas, PhD1,5,*, Xidao Wang, PhD2,*, Tasuku Akiyama, PhD3, Cordula Kempkes, PhD1, Terhi Savinko, PhD4, Attila Antal, MD5, Gabriela Kukova, MD5, Timo Buhl, MD1, Akihiko Ikoma, MD, PhD1, Joerg Buddenkotte, PhD6, Vassili Soumelis, MD7, Micha Feld, PhD5, Harri Alenius, PhD4, Stacey R. Dillon, PhD8, Earl Carstens, PhD3, Bernhard Homey, MD5,#,§, Allan Basbaum, PhD2,#,§, and Martin Steinhoff, MD, PhD1,5,#,§
1Depts. of Dermatology and Surgery, University of California San Francisco, San Francisco, CA, USA 2Depts. of Anatomy and W.M. Keck Foundation Center for Integrative Neuroscience, University California San Francisco, San Francisco, CA, USA 3Dept. of Neurobiology, University California Davis, CA, USA 4Unit of Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland 5Dept. of Dermatology, University Hospital Duesseldorf, Duesseldorf, Germany 6Dept. of Dermatology, University Hospital Muenster, Muenster Germany 7Dep. of Immunology, Institut Curie, Paris, France 8ZymoGenetics, Inc. (a Bristol-Myers Squibb Company) Seattle, WA, USA

Abstract
Background—Although the cytokine, interleukin-31 (IL-31), has been implicated in
inflammatory and lymphoma-associated itch, the cellular basis for its pruritic action is yet unclear.
Objective—To determine whether immune cell-derived IL-31 directly stimulates sensory neurons, and to identify the molecular basis of IL-31-induced itch.
Methods—We used immunohistochemistry and qRTPCR to determine IL-31 expression levels in mice and humans. Immunohistochemistry, immunofluorescence, qRTPCR, in vivo pharmacology, western blotting, single cell calcium and electrophysiology were used to examine the distribution, functionality and cellular basis of the neuronal IL-31 receptor (IL-31RA) in mice and humans.
Results—Among all immune and resident skin cells examined, IL-31 was predominantly produced by TH2 and to a significantly lesser extend by mature dendritic cells. Cutaneous and intrathecal injections of IL-31 evoked intense itch, and its concentration increased significantly in murine atopic-like dermatitis skin. Both human and mouse DRG neurons express IL-31RA, largely in neurons that co-express TRPV1. IL-31-induced itch was significantly reduced in TRPV1- and TRPA1-deficient mice, not c-kit or PAR-2 mice. In cultured primary sensory neurons, IL-31 triggered Ca2+-release and ERK1/2 phosphorylation, Inhibition of which blocked IL-31 signaling in vitro and reduced IL-31-induced scratching in vivo.
Conclusion—IL-31RA is a functional receptor expressed by a small subpopulation of IL-31RA+/TRPV1+/TRPA1+ neurons, and is a critical neuro-immune link between TH2 cells and sensory nerves for the generation of T cell-mediated itch. Thus, targeting neuronal IL-31RA may be effective in the management of TH2-mediated itch, including atopic dermatitis and cutaneous T cell lymphoma.
Keywords
cytokine; atopic dermatitis; sensory nerve; skin; TRP channel

© 2013 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.
#Addresses for correspondence: Martin Steinhoff, M.D., Ph.D., Departments of Dermatology and Surgery, University of California, San Francisco, 513 Parnassus Ave, Room S-1268, San Francisco, CA, 94143 USA, Phone: +1 415 476 6978, FAX: +1 415 476 0936, SteinhoffM@derm.ucsf.edu. Allan. I. Basbaum, Ph.D., Department of Anatomy, University of California, San Francisco, 1550 4th Street, San Francisco, CA, USA, Phone: +1 415 476 5270, FAX: +1 415 476 1974, Allan.Basbaum@ucsf.edu. Bernhard Homey, M.D.. Department of Dermatology. University Hospital Duesseldorf, Duesseldorf, Germany, Phone: +49 211 811 7600, FAX: +49 211 811 7316, bernhard.homey@uni-duesseldorf.de.
*contributed equally to this work; §Co-senior authors;
Author contribution:
F. C.: conducted most of the experiments, designed the study, wrote manuscript. X. W.: conducted in vivo and morphological experiments with F.C. T.A: performed single cell calcium measurement and electrophysiology recordings under supervision of E.C; T. S.: designed the study for the in vivo mouse models of AD under supervision of H.A; A.A, M.F.: performed human staining experiments of skin tissue and qPCR of cells under supervision of B.H.; C. K.: performed western blotting and wrote part of the manuscript; G. K.: performed human staining experiments of skin tissue and qPCR of cells; A. I.: assisted in cheek model assay; T. B.: stained human DRG for IL-31RA; H. A.: supervised the murine AD study; S. D.: supervised vivo mouse studies; E. C.: supervised electrophysiology study; B. H.: designed, supervised human IL-31 studies and mouse atopy models, and wrote manuscript; A.I.B.: designed, supervised the neuronal experiments, and wrote manuscript; M.S.: designed, supervised all experiments, analyzed data, and wrote manuscript.
Publisher’s Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Journal club 2015.07.10.

HTR7 Mediates Serotonergic Acute and Chronic Itch

HTR7 Mediates Serotonergic Acute and Chronic Itch

Takeshi Morita,1,2,7 Shannan P. McClain,1,7 Lyn M. Batia,1 Maurizio Pellegrino,1 Sarah R. Wilson,1,2 Michael A. Kienzler,3 Kyle Lyman,3 Anne Sofie Braun Olsen,3 Justin F. Wong,1 Cheryl L. Stucky,4 Rachel B. Brem,5,6,* and Diana M. Bautista1,2,* 1Department of Molecular & Cell Biology, 142 Life Sciences Addition, University of California, Berkeley, Berkeley, CA 94720-3200, USA 2Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA
3Neurobiology Course, Marine Biological Laboratory, Woods Hole, MA 02543, USA
4Departments of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA 5Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA
6Department of Plant and Microbial Biology, University of California, Berkeley, Berkeley, CA 94720, USA
7Co-first author
*Correspondence: rbrem@buckinstitute.org (R.B.B.), dbautista@berkeley.edu (D.M.B.) http://dx.doi.org/10.1016/j.neuron.2015.05.044

SUMMARY
Chronic itch is a prevalent and debilitating condition for which few effective therapies are available. We harnessed the natural variation across genetically distinct mouse strains to identify transcripts co-re- gulated with itch behavior. This survey led to the discovery of the serotonin receptor HTR7 as a key mediator of serotonergic itch. Activation of HTR7 promoted opening of the ion channel TRPA1, which in turn triggered itch behaviors. In addition, acute itch triggered by serotonin or a selective serotonin reuptake inhibitor required both HTR7 and TRPA1. Aberrant serotonin signaling has long been linked to a variety of human chronic itch conditions, in- cluding atopic dermatitis. In a mouse model of atopic dermatitis, mice lacking HTR7 or TRPA1 dis- played reduced scratching and skin lesion severity. These data highlight a role for HTR7 in acute and chronic itch and suggest that HTR7 antagonists may be useful for treating a variety of pathological itch conditions.

Journal Club 2015.06.12.

RESEARCH ARTICLE

Five hTRPA1 Agonists Found in Indigenous Korean Mint, Agastache rugosa

journal.pone.0127060

Hana Moon1☯, Min Jung Kim1☯, Hee Jin Son1, Hae-Jin Kweon2, Jung Tae Kim1, Yiseul Kim1, Jaewon Shim1, Byung-Chang Suh2, Mee-Ra Rhyu1*
1 Research Group of Food Functionality, Korea Food Research Institute, Bundang-gu, Sungnam-si, Gyeonggi-do, Republic of Korea, 2 Department of Brain Science, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, Republic of Korea
☯ These authors contributed equally to this work. * mrrhyu@kfri.re.kr

Abstract
Transient receptor potential ankyrin1 (TRPA1) and transient receptor potential vanilloid 1 (TRPV1) are members of the TRP superfamily of structurally related, nonselective cation channels and mediators of several signaling pathways. Previously, we identified methyl syr- ingate as an hTRPA1 agonist with efficacy against gastric emptying. The aim of this study was to find hTRPA1 and/or hTRPV1 activators in Agastache rugosa (Fisch. et Meyer) O. Kuntze (A.rugosa), commonly known as Korean mint to improve hTRPA1-related phenome- na. An extract of the stem and leaves of A.rugosa (Labiatae) selectively activated hTRPA1 and hTRPV1. We next investigated the effects of commercially available compounds found in A.rugosa (acacetin, 4-allylanisole, p-anisaldehyde, apigenin 7-glucoside, L-carveol, β- caryophyllene, trans-p-methoxycinnamaldehyde, methyl eugenol, pachypodol, and ros- marinic acid) on cultured hTRPA1- and hTRPV1-expressing cells. Of the ten compounds, L-carveol, trans-p-methoxycinnamaldehyde, methyl eugenol, 4-allylanisole, and p-anisal- dehyde selectively activated hTRPA1, with EC50 values of 189.1±26.8, 29.8±14.9, 160.2 ±21.9, 1535±315.7, and 546.5±73.0 μM, respectively. The activities of these compounds were effectively inhibited by the hTRPA1 antagonists, ruthenium red and HC-030031. Al- though the five active compounds showed weaker calcium responses than allyl isothiocya- nate (EC50=7.2±1.4 μM), our results suggest that these compounds from the stem and leaves of A.rugosa are specific and selective agonists of hTRPA1.

Journal Club 2015.4.24

Pain-sensing TRPA1 channel resolved
nature14383

The TRPA1 ion channel activates pain pathways in response to noxious compounds. The structure of TRPA1 has now been solved, providing insight into how it functions.Pain-sensing TRPA1 channel resolved

Journal Club 2015.4.17

Structure of the TRPA1 ion channel suggests regulatory mechanisms

Candice E. Paulsen1*, Jean-Paul Armache2*, Yuan Gao1,2, Yifan Cheng2 & David Julius1

doi:10.1038/nature14367 nature14367

The TRPA1 ion channel (also known as the wasabi receptor) is a detector of noxious chemical agents encountered in our environment or produced endogenously during tissue injury or drug metabolism. These include a broad class of electrophiles that activate the channel through covalent protein modification. TRPA1 antagonists hold potential for treating neurogenic inflammatory conditions provoked or exacerbated by irritant exposure. Despite compelling reasons to understand TRPA1 function, structural mechanisms underlying channel regulation remain obscure. Here we use single-particle electron cryo- microscopy to determine the structure of full-length human TRPA1 to 4 A ̊ resolution in the presence of pharmacophores, including a potent antagonist. Several unexpected features are revealed, including an extensive coiled-coil assembly domain stabilized by polyphosphate co-factors and a highly integrated nexus that converges on an unpredicted transient receptor potential (TRP)-like allosteric domain. These findings provide new insights into the mechanisms of TRPA1 regulation, and establish a blueprint for structure-based design of analgesic and anti-inflammatory agents.

journal club 2015-03-06

5-HT3 receptors antagonists reduce serotonin-induced scratching in mice

Running title: 5-HT3 receptors mediate serotonin-induced scratching

fcp12112

Sattar Ostadhadi a,b, Nastaran Kordjazy a,b, Arya Haj-Mirzaian a,b, Parvin Mansouri c, Ahmad Reza Dehpour a,b*

a Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

b Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

c Skin and Stem cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

* Corresponding author:

Prof. Ahmad Reza Dehpour, PharmD, PhD, Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran. Tel: +98 21 88973652, fax: + 98 21 66402569, e-mail: dehpoura@sina.tums.ac.ir

 

ABSTRACT

Serotonin (5-hydroxytryptamine, 5-HT) acts as a pruritogen in humans and animals, but the mechanisms of action through that serotonin induces itch-response have not been extensively discovered. In our study, we attempted to investigate the role of 5-HT3 receptors in scratching behavior due to intradermal serotonin injection. Intradermal injection of serotonin (14.1–235 nmol/site) into the nape of the neck of mice was performed to elicit itch. Scratching behavior was evaluated by measuring the number of bouts during 60 minutes after injection. We evaluated the effect of intraperitoneal pretreatment with ondansetron and tropisetron (0.1, 0.3, and 1 mg/kg) on itch induced by serotonin. Also, intradermal ondansetron and tropisetron at doses 50, 100, and 200 nmol/site were concurrently administrated with serotonin. Serotonin produced a significant enhancement in scratching at dose 141 nmol/site. Concurrent administration of ondansetron (50, 100, and 200 nmol/site) and tropisetron (100 and 200 nmol/site) with serotonin reduced scratching activity compared to the animals that only received serotonin. Also, pretreatment with intraperitoneal ondansetron and tropisetron (0.3 and 1 mg/kg) 30 min before serotonin attenuated the itch response. We showed that the scratching induced by intradermal serotonin is mediated by 5-HT3 receptors subtype. It can be concluded that 5-HT3 may play a role in mediating serotonin-associated itch responses, and we introduce 5-HT3 receptors as possible targets for antipruritic agents.

Key words: Scratching; Serotonin (5-HT); 5-HT3 antagonists; Mice

Scroll to Top